Navigation Links
Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
Date:10/17/2010

primates that are used to predict abuse liability of compounds, NKTR-181 showed a marked reduction in self-administration of drug as compared to both oxycodone and morphine.  Additionally, in a series of in situ brain perfusion studies, NKTR-181 exhibited a significantly reduced rate of entry into the CNS as compared to oxycodone.  

These data were presented at Anesthesiology 2010: American Society of Anesthesiologists Annual Meeting during the poster session entitled "Chronic and Cancer Pain":

  • Fishburn et al., "NKTR-181, a Novel Opioid Analgesic with Slow Entry into the CNS and Markedly Reduced CNS Side Effects" (Abstract A509), October 17, 2010, 9:00 – 11:00 AM Pacific time, Room Hall B1-Area G.

  • The poster presentation can be found on Nektar's website at www.nektar.com.

    About Opioids and Pain ManagementPain is the most common symptom for which patients seek medical attention.(1)  According to the American Pain Society, the prevalence of chronic pain in the United States is estimated to be 35.5% or 105 million people.  Chronic pain costs more than $100 billion per year in direct health-care expenditures and lost work time. Opioids are considered to be the most effective therapeutic option for pain and have over $10 billion a year in sales in the U.S. alone.(2,3)  However, opioids cause significant problems for physicians and patients because of their serious side effects such as respiratory depression and sedation, as well as the risks they pose for addiction, abuse, misuse, and diversion. The U.S. Food and Drug Administration has cited prescription opioid analgesics as being at the center of a major public health crisis of addiction, misuse, abuse, overdose and death.(4)  A 2010 recent report from the Center for Disease Control and Prevention (CDC) notes that emergency room visits tied to the abuse of prescription painkillers is at an all-t
    '/>"/>

    SOURCE Nektar Therapeutics
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
    2. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
    3. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
    4. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
    5. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
    6. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
    7. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
    8. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
    9. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
    10. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
    11. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... WYNNEWOOD, Pa. , Jan. 23, 2015  MedScope ( ... has been nominated for a 2015 Connected World ... Personal Emergency Response System (mPERS), that can be used ... M2M technology partner.  In nominating MedScope, ...
    (Date:1/23/2015)... , Jan. 23, 2015  Pete Rose, baseball,s all-time hits ... and arthritis pain reliever Myoflex, Ducere Pharma has announced. ... we are excited to have him on board with Myoflex," ... "He is a legendary player who is known across all ...
    (Date:1/23/2015)... SETAUKET, N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, ... where its Phase I trial of Lixte,s lead compound, LB‑100, ... institutions. John S. Kovach , M.D., the ... was planned to be completed at a single site. Accrual ...
    Breaking Medicine Technology:MedScope Nominated by RacoWireless for Prestigious 2015 Connected World Magazine Connected World Award 2Pete Rose bets on Myoflex to relieve aches and pains 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
    ... Premature Births, WATSONVILLE, Calif., Feb. 5 The ... acid supplements greatly,reduced the risk of premature birth. Meanwhile, ... supplements., It,s often hard for people to remember ... benefit from this B vitamin need only visit their,supermarket,s ...
    ... Feb. 5 Researchers are,identifying innovative therapeutics for ... the disease,s progression, such as the important role,of ... a study prepublished,online in Blood, the official journal ... molecule therapy called senicapoc showed efficacy,in maintaining hydration ...
    Cached Medicine Technology:Folate in Strawberries May Contribute to Healthy Pregnancy 2Novel Small Molecule Therapy Shows Benefit for Anemic Patients Via Hydration of Red Blood Cells 2Novel Small Molecule Therapy Shows Benefit for Anemic Patients Via Hydration of Red Blood Cells 3
    (Date:1/22/2015)... (PRWEB) January 22, 2015 Deer Path of ... host a Valentine’s Day Happy Hour from 3 p.m. to 4 ... 12500 Regency Parkway in Huntley, Illinois, serves adults with physical disabilities ... event will include Valentine's Day treats, games and sweetheart-themed karaoke. , ...
    (Date:1/22/2015)... Woodloch Pines, an all-inclusive family resort ... TripAdvisor as the number one best large hotel for families ... world for their annual Travelers’ Choice Awards. , TripAdvisor ... website is home to millions of unbiased and honest traveler ...
    (Date:1/22/2015)... Angelweddingdress is a famous wedding dress company offering many ... it on Facebook, Twitter, and Pinterest. The fans will have ... a lottery every week. , Moreover, the company has extended ... Angelweddingdress homepage for more information. , Angelweddingdress ...
    (Date:1/22/2015)... A new white paper by The Beryl Institute ... long-term care environment as well as provides recommendations for ... “The Power of Person-Centeredness in Long-Term Care: A View ... patient, resident and family experience in long-term care and ...
    (Date:1/22/2015)... Joan Lunden, award-winning American journalist, beloved ... upcoming 32nd Annual Miami Breast Cancer Conference ... LLC (PER®) , shares that “a fast-growing, virulent” cancer ... she had not followed up her clean mammogram with ...
    Breaking Medicine News(10 mins):Health News:Deer Path of Huntley Affordable Assisted Living to Host Valentine's Day Happy Hour 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6
    ... Low Donation Rates, Encourage New,York Blood Donor Diversity, ... New York,Blood Center (NYBC), the nation,s largest community-based, ... blood "donor,coach," funded by a $160,000 grant from ... MetLife,s mascot, making it an,eye-catching reminder, in the ...
    ... 20 BioForm Medical,Inc. (Nasdaq: BFRM ) ... BioForm Medical will present a company overview at ... June 24-26th, 2008,in New York. BioForm Medical,s presentation ... 8:30 a.m. EDT., A live and archived ...
    ... Appeal Hearing, TORONTO, June 20 /PRNewswire-FirstCall/ - ... today announced the successful completion,of its agreement with ... a result of the completion of this project, ... company for further product development and,other skin testing ...
    ... Finnish study urges this 3rd category be added ... 20 (HealthDay News) -- Hazardous drinking -- drinking ... needs to be recognized as a genuine public ... disorders are divided into two categories: alcohol abuse/harmful ...
    ... of lesions seen on MRIs with limited side effects, study ... the first pills to treat the "relapse-remitting" form of multiple ... few side effects. , Although the drug, laquinimod, is still ... convenient for many patients. , "By and large, this doesn,t ...
    ... June 20 From June 20, 2008 through,June 27, ... around the,United States and the world will gather at ... Little People of America (LPA),Conference in downtown Detroit., ... the City of,Detroit to bring global solutions and awareness ...
    Cached Medicine News:Health News:MetLife Foundation Partners with New York Blood Center to Introduce 'Donor Coach' to New York Boroughs 2Health News:MetLife Foundation Partners with New York Blood Center to Introduce 'Donor Coach' to New York Boroughs 3Health News:PreMD Successfully Completes Project for Health & Beauty Company 2Health News:'Hazardous Drinking' More Common Than Thought 2Health News:Experimental Drug Fights Multiple Sclerosis Activity 2Health News:Experimental Drug Fights Multiple Sclerosis Activity 3
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    Medicine Products: